Vaxart, Inc.
VXRT
$0.48
-$0.03-5.10%
OTC PK
| 06/30/2026 | 03/31/2026 | ||||
|---|---|---|---|---|---|
| Revenue | -30.70% | -62.37% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -30.70% | -62.37% | |||
| Cost of Revenue | 14.76% | -34.85% | |||
| Gross Profit | -166.93% | -83.39% | |||
| SG&A Expenses | 42.28% | 26.60% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 18.51% | -30.24% | |||
| Operating Income | -354.63% | -90.67% | |||
| Income Before Tax | -358.54% | -90.60% | |||
| Income Tax Expenses | 0.00% | -91.57% | |||
| Earnings from Continuing Operations | -360.55% | -90.59% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -360.55% | -90.59% | |||
| EBIT | -354.63% | -90.67% | |||
| EBITDA | -297.35% | -89.04% | |||
| EPS Basic | -359.07% | -90.79% | |||
| Normalized Basic EPS | -357.78% | -90.80% | |||
| EPS Diluted | -378.50% | -91.39% | |||
| Normalized Diluted EPS | -359.70% | -90.86% | |||
| Average Basic Shares Outstanding | 0.63% | 2.03% | |||
| Average Diluted Shares Outstanding | -0.01% | 2.55% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||